CION Investment Corporation
CION Investment Corporation (CION) Financial Performance & Income Statement Overview
Review CION Investment Corporation (CION) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
CION Investment Corporation (CION) Income Statement & Financial Overview
Explore comprehensive income reports for CION Investment Corporation CION, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | -$16.59M | $33.94M | $59.63M | $41.08M |
Cost of Revenue | $23.00M | $0.00 | $0.00 | $13.08M |
Gross Profit | -$39.59M | $8.70M | $59.63M | $28.00M |
Gross Profit Ratio | $2.39 | $0.26 | $1.00 | $0.68 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $3.00M | $3.00M | $1.85M | $2.78M |
Operating Expenses | $3.12M | $3.12M | $38.03M | $2.90M |
Total Costs & Expenses | $26.11M | $28.36M | $38.03M | -$5.08M |
Interest Income | $51.39M | $51.36M | $40.61M | $53.86M |
Interest Expense | $23.00M | $25.24M | $23.55M | $23.77M |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$46.74M |
EBITDA | -$42.70M | $5.58M | $0.00 | $0.00 |
EBITDA Ratio | $2.57 | $0.16 | $0.00 | $0.00 |
Operating Income | -$42.70M | $5.58M | $21.60M | $46.16M |
Operating Income Ratio | $2.57 | $0.16 | $0.36 | $1.12 |
Other Income/Expenses (Net) | $0.00 | $0.00 | -$22.00M | -$24.36M |
Income Before Tax | -$42.70M | $5.58M | -$400000.00 | $22.38M |
Income Before Tax Ratio | $2.57 | $0.16 | -$0.007 | $0.54 |
Income Tax Expense | $0.00 | $119000.00 | -$21000.00 | $4000.00 |
Net Income | -$42.70M | $5.46M | $21.60M | $22.38M |
Net Income Ratio | $2.57 | $0.16 | $0.36 | $0.54 |
EPS | -$0.80 | $0.10 | $0.40 | $0.42 |
Diluted EPS | -$0.80 | $0.10 | $0.40 | $0.42 |
Weighted Avg Shares Outstanding | $53.07M | $53.56M | $53.44M | $53.60M |
Weighted Avg Shares Outstanding (Diluted) | $53.07M | $53.56M | $53.44M | $53.60M |
The company's financials show resilient growth, with revenue advancing from $41.08M in Q2 2024 to -$16.59M in Q1 2025. Gross profit remained healthy with margins at 239% in Q1 2025 compared to 68% in Q2 2024. Operating income hit -$42.70M last quarter, sustaining a consistent 257% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$42.70M. Net income dropped to -$42.70M, while earnings per share reached -$0.80. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan